Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Nirmish Singla MD, MSCS

Nirmish Singla MD, MSCS

Urologic Oncologist, Brady Urological Institute, Johns Hopkins, Director of Translational Research in Genitourinary Oncology, JOhns Hopkins, Baltimore, MD

Dr. Singla is a urologic oncologist in the Brady Urological Institute at Johns Hopkins, where he serves as the Director of Translational Research in Genitourinary Oncology. He is also the Director of the Kidney Cancer Program and Testicular Cancer Program, and he co-directs the Upper Tract Urothelial Cancer Multidisciplinary Clinic.

Dr. Singla received his undergraduate degree (B.S.E.) in Biomedical Engineering from the University of Michigan and his medical degree (M.D.) from the University of Michigan Medical School, where he was supported by a full-tuition Dean’s Merit Scholarship.  He went on to complete his residency training in Urologic Surgery at the University of Texas Southwestern Medical Center (UTSW), where he served as Administrative Chief Resident.  Following his residency, he received an NIH/NCI Ruth L. Kirschstein National Research Service Award T32 grant and spent an additional year at UTSW as a postdoctoral research fellow in Urologic Oncology through the Physician Scientist Training Program.  During this time, he earned a Master of Science in Clinical Science (M.S.C.S.) degree through the Center for Translational Medicine at UTSW and helped develop and pioneer a Physician Administrative Fellowship program.  He then completed a specialized clinical fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center (MSKCC) in New York through the Society of Urologic Oncology (SUO) before joining Johns Hopkins.